Myriad Genetics EV/EBITDA Ratio 2011-2026 | MYGN

Annual EV/EBITDA Ratio Myriad Genetics

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-17.2	-15.4	28.3	25.6	16.5	10.9	14.7	9.42	9.83	11.1	11.3

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
28.3	-17.2	9.54

EV/EBITDA Ratio of other stocks in the Diagnostics research industry

Issuer	EV/EBITDA Ratio	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	0.387	-	-6.23 %	$ 30.6 M	Germany
Agilent Technologies A	27.4	$ 114.84	-0.55 %	$ 34.9 B	USA
Oxford Immunotec Global PLC OXFD	-73.4	-	-	$ 562 M	Britain
Akumin AKU	28.1	-	-17.87 %	$ 25.9 M	Canada
Burning Rock Biotech Limited BNR	-1.51	$ 16.3	0.62 %	$ 175 M	China
Aspira Women's Health AWH	-2.63	-	-6.19 %	$ 10.5 M	USA
Accelerate Diagnostics AXDX	-5.56	-	-61.36 %	$ 2.46 M	USA
Global Cord Blood Corporation CO	-3.52	-	-	$ 399 M	China
Fluidigm Corporation FLDM	-13.6	-	1.08 %	$ 308 M	USA
Genetic Technologies Limited GENE	-2.67	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	-2.67	-	0.12 %	$ 80.1 M	China
PRA Health Sciences, Inc. PRAH	20.8	-	-	$ 10.7 B	USA
Biocept BIOC	-26.9	-	-13.05 %	$ 7.29 M	USA
Biodesix BDSX	-4.25	$ 15.36	1.92 %	$ 1.99 B	USA
Koninklijke Philips N.V. PHG	55.6	$ 27.2	0.33 %	$ 20 B	Niderland
QIAGEN N.V. QGEN	13.2	-	-	$ 10.6 B	Niderland
CareDx, Inc CDNA	-100	$ 17.82	-2.68 %	$ 950 M	USA
Anixa Biosciences ANIX	-2.25	$ 2.59	1.57 %	$ 84.1 K	USA
Biomerica BMRA	-6.24	$ 2.17	-	$ 4.98 M	USA
BioNano Genomics BNGO	-7.71	$ 1.15	-4.17 %	$ 6.26 M	USA
Check-Cap Ltd. CHEK	-0.674	-	-	$ 9.42 M	Israel
Co-Diagnostics CODX	3.62	$ 4.4	101.83 %	$ 5.85 M	USA
Charles River Laboratories International CRL	22	$ 168.22	-3.26 %	$ 8.34 B	USA
Castle Biosciences CSTL	-21.2	$ 24.73	-0.44 %	$ 687 M	USA
Celcuity CELC	-2.38	$ 114.22	1.41 %	$ 5.34 B	USA
Danaher Corporation DHR	20.1	$ 192.12	0.53 %	$ 137 B	USA
DermTech DMTK	-2.44	-	-11.32 %	$ 2.94 M	USA
DexCom DXCM	39.5	$ 63.21	1.59 %	$ 24.7 B	USA
Chembio Diagnostics CEMI	-1.23	-	0.22 %	$ 16.8 M	USA
Enzo Biochem ENZ	58.3	-	-8.98 %	$ 14.8 K	USA
Exact Sciences Corporation EXAS	-20.8	-	-	$ 19.8 B	USA
Quest Diagnostics Incorporated DGX	5.51	$ 198.96	0.91 %	$ 22.1 B	USA
Fulgent Genetics FLGT	2.58	$ 16.42	-2.38 %	$ 496 M	USA
Guardant Health GH	-28.8	$ 89.66	-4.44 %	$ 11.2 B	USA
Heska Corporation HSKA	141	-	-	$ 1.31 B	USA
HTG Molecular Diagnostics HTGM	-1.42	-	-20.0 %	$ 1.06 M	USA
ICON Public Limited Company ICLR	38	$ 109.62	-4.0 %	$ 9.04 B	Irlanda
Interpace Biosciences IDXG	-6.02	$ 1.97	0.63 %	$ 8.72 M	USA
Illumina ILMN	70.5	$ 127.74	0.28 %	$ 20.3 B	USA
IQVIA Holdings IQV	24.1	$ 170.72	-1.47 %	$ 29.3 B	USA
Laboratory Corporation of America Holdings LH	8.7	$ 274.46	0.27 %	$ 22.8 B	USA
Lantheus Holdings LNTH	-187	$ 75.89	-0.28 %	$ 5.12 B	USA
Medpace Holdings MEDP	30.7	$ 496.0	-0.47 %	$ 14.3 B	USA
Motus GI Holdings MOTS	0.351	-	-34.28 %	$ 263 K	Israel
Mettler-Toledo International MTD	827	$ 1 266.63	0.53 %	$ 26.1 B	Schweiz
ENDRA Life Sciences NDRA	0.831	$ 4.74	1.07 %	$ 3.73 M	USA
NeoGenomics NEO	-33.5	$ 8.02	0.25 %	$ 1.03 B	USA
Neogen Corporation NEOG	40.3	$ 9.56	1.59 %	$ 2.07 B	USA
National Research Corporation NRC	21	$ 17.33	0.99 %	$ 388 M	USA